Spectrum Pharma News - Web spectrum pharmaceuticals provides update on poziotinib following fda oncologic drugs advisory committee. (“assertio” or the “company”) (nasdaq:. Web spectrum pharmaceuticals reports first quarter 2023 financial results and corporate update.
Web spectrum pharmaceuticals reports first quarter 2023 financial results and corporate update. Web spectrum pharmaceuticals provides update on poziotinib following fda oncologic drugs advisory committee. (“assertio” or the “company”) (nasdaq:.